“…Serous tubal intraepithelial carcinoma (STIC), characterized by non-ciliated tubal epithelial cells that show marked nuclear atypia, mitotic figures, apoptotic bodies, loss of cellular polarization, abnormal p53 staining (a pattern compatible with either missense or deletion mutations), and an increased Ki-67 labeling index, has been recognized as a precancerous lesion of HGSC [ 2 ]. It is often found in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in hereditary breast and ovarian cancer (HBOC) patients with pathogenic variants of BRCA1 and BRCA2 and also found in fallopian tube tissue from patients with HGSC [ 3 4 5 6 ]. The coincidental finding of the TP53 mutation in both HGSC and STIC has led to the recognition of STIC as an early lesion and the TP53 mutation as an early driver mutation of HGSC [ 1 7 8 9 10 11 ].The similarity in morphology, immunophenotype, and gene expression patterns between fallopian tube epithelium and HGSC provides additional evidence that HGSC develops from the fallopian tube [ 12 ].…”